FDA NEWS RELEASE
For Immediate Release: July 9, 2012
Media Inquires: Twitter: @DyadGame
Consumer Inquires:
http://www.dyadgame.com
FDA approves Dyad for gamers with "PlayStation 3 Possession Syndrome" and "Dyad Desire
Syndrome" for public consumption on July 17, 2012 in North America for $14.99 with a 20%
discount for PlayStation Plus members via the PlayStation network.
Today, Dyad was approved by the U.S. Food and Drug Administration to administer heroic
doses of ultimate sensory overload. It is absorbed directly into gamers' cerebral cortex via their
eyes, ears and thumbs. The game was approved for use in all patients in North America who
are in possession of a PlayStation 3 console, and are not susceptible to epileptic seizures or
other abnormal excessive or synchronous neuronal activity in the brain.
Research on Dyad began in 2008 at CERN by Shawn McGrath. After CERN officials observed
test subjects wholly absorbed in euphoric trances and reviewed testimonies of transcendental
interactive experiences, CERN halted development of Dyad and expelled Shawn. Determined
to finish his research and enlighten gamers worldwide, Shawn partnered with composer David
Kanaga and continued developing Dyad in secret. The misnomer "the god particle" has been
the headline of choice for journalists since CERN's recent discovery of the Higgs Boson. This
dialectic dereliction prompted Dyad's immediate release to stimulate gamers' sense of discovery
and aid in the search for their own "god particle."
On July 17 gamers are encouraged to drop into Dyad to experience a mind-bending harmonious
synthesis of colour and sound while hooking, grazing and lancing their way to mastery of
Dyad's 27 sensory scrambling psychedelic stages. A Platinum Trophy is awarded to those
with a focused mind's eye who are able to conquer Dyad's 26 tactical freakout Trophy levels.
Dyad's 26 relaxing hallucinogenic Remix levels are ideal for gamers with a cardiac condition or
an elevated risk of heart complications. Dyad provides relief to gamers with enhanced ocular
sensitivity and acute aural awareness by delivering superfluous stimulation at 1080p, 60fps and
uncompressed audio.